Private Equity

Updated:

Evolvient Capital

Evolvient Capital is a London-based firm founded in 2022. It invests in businesses, making 5 investments to date.

Evolvient Capital logo

Evolvient Capital

Evolvient Capital is a London-based firm founded in 2022. It invests in businesses, making 5 investments to date. Its latest investment was in Koios, a Pre-Seed round completed on September 05, 2023.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

United Kingdom

City

London

Corporate office

1 Poultry, London, EC2R 8EJ, United Kingdom

Principals

Ian Temple

Managing Partner

John Hunter

Managing Partner

Frequently asked questions

Who runs investment decisions at Evolvient Capital?

Managing Partners Ian Temple and John Hunter jointly run the firm. Temple previously built and sold recruitment business Hydrogen Group, while Hunter co-founded Argyll Scott and later merged it into Hydrogen. Their biographies, sourced from the firm's own website, describe a partnership with no additional investment committee or external advisors disclosed.

How does Evolvient Capital source deal flow?

Evolvient does not articulate a formal sourcing model. Temple and Hunter's professional networks — spanning three decades across the UK and Asia-Pacific recruitment sectors — appear central. The firm's website emphasizes direct relationships with entrepreneurs and a philosophy of backing leaders they know, consistent with a founder-dependent origination approach typically seen in informal family offices or angel syndicates.

Is Evolvient Capital structured as a single family office or a private equity firm?

Evolvient labels itself a private equity firm and does not reference any single-family wealth source. The partners deploy their own capital, based on their liquidity events from Hydrogen Group and Argyll Scott, but they have not disclosed whether the firm manages outside money or operates a commingled fund. The absence of a revealed fund structure or limited partner base keeps its precise classification ambiguous.

What investment stages does Evolvient Capital target?

The firm states it works from 'start-ups to scale-ups,' but its three named portfolio holdings — Tempting Ventures, Project Partners, and Strategio — were all early-stage ventures at the time of backing. Evolvient does not publish minimum or maximum check sizes, making it impossible to confirm whether it participates in later growth rounds beyond its initial seed- and Series A-stage posture.

Which sectors does Evolvient Capital explicitly avoid?

Evolvient does not maintain a public exclusion list. Its mandate is described simply as 'purpose-led' businesses that solve real-world needs. Without a sector-specific investment policy or compliance disclosure, no formal negative screen — such as restrictions on defense, extractive industries, or predatory lending — is available to an allocator evaluating the firm.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More London Private Equity profiles